While there are still many questions about TCF7L2 left unanswered, it has been shown that TCF7L2 is essential to the production of proglucagon via the intestinal cells (not the glucagon produced in the alpha cells of the pancreas).[ref] Genetic variants in TCF7L2 are associated with impaired glucose stimulation of insulin secretion and GLP-1.[ref] GLP1R (glucagon-like peptide 1 receptor) receives the signal from GLP-1, and variants in GLP1R have associations with altered BMI, weight, and insulin resistance
Androgen receptor (AR) and estrogen receptor (ER) signaling pathways undergo significant impairment, compromising testosterone biosynthesis and normal spermatogenesis
PubMed laboratory research record [PMID: 38904969] PubMed record related to this compound for laboratory literature review
Injection Site Reactions: Many GLP-1 medications are administered via subcutaneous injection, which can lead to injection site reactions such as redness, itching, or swelling
It stays active for a longer period and is more potent than regular IGF-1 in research models